PRQR
ProQR Therapeutics N.V.
NASDAQ · Healthcare · Biotechnology · NL
$2.07
−0.96%Leverage
- Debt / equity
- 0.17x
- Net debt / equity
- -1.31x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -0.35x
- Net debt / EBITDA
- 2.76x
Liquidity & coverage
- Current ratio
- 3.49x
- Quick ratio
- 3.49x
- Cash ratio
- 3.36x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $100.8M
Cash & dividend
- FCF / debt
- -3.81x
- Cash flow / debt
- -3.73x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026